SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-06 |
| Reported value | $229,453,865 |
| Positions | 2 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| Mineralys Therapeutics, Inc. | MLYS | COM | $213,245,549 | 7,903,838 |
| Phathom Pharmaceuticals, Inc. | PHAT | COM | $16,208,316 | 1,493,854 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.